12:00 AM
 | 
Sep 24, 2007
 |  BioCentury  |  Finance

Domain exits

Domain exits

Company Description
Cabrellis [acq'd by Pharmion] Spun out of Conforma when that company was acquired by Biogen Idec; Cabrellis had North American and European rights to amrubicin from Dainippon Sumitomo; the drug is marketed as Calsed in Japan for non-small and small cell lung...

Read the full 246 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >